Merck's COVID-19 antiviral pill is the second authorized by the FDA
The FDA has approved a second COVID-19 antiviral pill, but Merck's offering might not get as much uptake as its Pfizer rival..
Stay updated with breaking news from While Pfizer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has approved a second COVID-19 antiviral pill, but Merck's offering might not get as much uptake as its Pfizer rival..
Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.
Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.
Pfizer's COVID-19 antiviral pill will already have some competition in the US: The Food and Drug Administration has given emergency use authorization for Merck's Molnupiravir pill.
We're maintaining our fair value estimates for mRNA vaccine firms.